Osmetech (fka osmef)

[ditchpig]

<font color=RED> <font size=3>Welcome to Osmetech - LSE:OMH OTC:OSMEF


Hello all.
Hope you find something of interest in this thread.
The company has made some huge leaps forward in the last 18 months and the next 12 will see the company bring some world leading products to market.

VIP5 a device to test for multiple sexual diseases in a point of care setting. market size for such a product is estimated at being $20 billion.

Genedrive is a product which gives the company a strong entry point into the fastest growing market segment of DNA based diagnostics. Molecular diagnostics is the fastest growing market segment within the $20bn+ global diagnostics market, with annual growth of 20%+ expected to continue for the foreseeable future.

The company has recently recruited two highly regarded molecular diagnostics specialist to commercialise this technology.
http://www.osmetech.com/news/2004/pr131204_mgmt_mole_diag.htm

The group is well funded having around $6,000,000 in the bank at the last results and a well established product, OPTI, earning more than $6,000,000 a year. The company has recently launched an arterial blood sampler which is expected to generate revenues in excess of $2,000,000 a year but more importantly has just launched a new vetinary product, Vetstat, for Idexx.

Results are out on the 27 January and if you are looking for a short term punt a good run is expected over the next 4 trading days. Long term they look a very safe bet.

Have fun and good luck.
DP